ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,669Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 448

$2.6M Total Retail Price of All Prescriptions

Rank: 3 out of 448

982 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 982 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 14,950 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

54% of this provider’s prescriptions were for brand-name drugs, compared to an average of 45%.

Prescription Price

$132 was the average price of a prescription from this provider, compared to $111 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
GLIMEPIRIDE 1,101 833 10 1 7
SIMVASTATIN 961 762 2 4
JANUVIA 908 720 10 3 6
LEVOTHYROXINE SODIUM 821 596 4 1
ATORVASTATIN CALCIUM 798 600 5 13
METFORMIN HCL 722 510 6 2
CRESTOR 611 490 7 22
SYNTHROID 583 410 8 3
ZETIA 576 373 9 41
ONGLYZA 543 425 10 10 58
PEN NEEDLE 494 354 11 5
LOSARTAN POTASSIUM 491 416 12 16
LEVEMIR FLEXPEN 480 383 10 13 35
ACARBOSE 471 348 10 14 70
AMLODIPINE BESYLATE 451 375 15 12
ACTOS 382 299 16 20
CARVEDILOL 381 332 17 36
HYDROCHLOROTHIAZIDE 348 287 18 27
NIASPAN 338 210 19 92
METFORMIN HCL ER 312 254 20 19
LISINOPRIL 284 195 21 14
NOVOLOG FLEXPEN 273 212 22 28
WELCHOL 269 195 23 114
INSULIN SYRINGE 260 219 24 9
BYETTA 260 183 10 24 47
METHIMAZOLE 248 208 26 24
HUMALOG 242 193 27 11
TRILIPIX 241 168 28 123
LOVAZA 229 91 29 43
LANTUS 226 176 30 8
NOVOLOG 218 132 31 34
BYSTOLIC 217 185 32 128
VICTOZA 3-PAK 205 126 33 64
VYTORIN 204 165 34 107
DIOVAN 193 170 35 23
LEVEMIR 192 129 36 83
LIPITOR 178 125 37 56
GLIPIZIDE 155 128 38 15
ACTOPLUS MET 149 101 39 117
LEVOXYL 147 116 40 18
FUROSEMIDE 147 121 40 25
LANTUS SOLOSTAR 138 110 42 10
BENICAR 128 72 43 111
VICTOZA 2-PAK 118 76 44 135
ALENDRONATE SODIUM 113 91 45 17
AMLODIPINE BESYLATE-BENAZEPRIL 110 106 46 130
PIOGLITAZONE HCL 110 91 R 46 66
LOSARTAN-HYDROCHLOROTHIAZIDE 107 91 48 50
RAMIPRIL 104 82 49 85
FENOFIBRATE 99 56 50 59
BENAZEPRIL HCL 88 58 51 38
JANUMET 73 58 52 32
KOMBIGLYZE XR 69 64 53 198
CALCITRIOL 67 53 54 54
HUMULIN R 67 27 54 132
ACTONEL 65 63 56 84
HYDROCORTISONE 64 39 57 91
TRICOR 63 56 58 106
PRAVASTATIN SODIUM 63 51 58 31
POTASSIUM CHLORIDE 62 47 60 55
PLAVIX 56 55 61 75
CLONIDINE HCL 53 36 62 72
DIOVAN HCT 52 39 63 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.